The Effect of Pharmaceutical Excipients on Protein Chemical Degradation Through Deamidation and Isomerization
Pharmaceutical Research · 2026-04 · 43 (4) · 1227-1240
DOI: 10.1007/s11095-026-04040-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, online erschienen am 13.03.2026. Verfasst von Ingrid Ramm und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Process and Life Science Engineering, Lund University, 221 00, Lund, Sweden. Hauptthemen laut MEDLINE: Excipients. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VINNOVA, Lund University.
Abstract (Originalsprache)
Introduction
Therapeutic proteins are crucial in the treatment of a wide range of diseases. However, the proteins are sensitive to chemical degradation reactions, particularly deamidation and isomerization, which can compromise efficacy and safety. Formulation excipients, such as sugars and non-ionic surfactants, are commonly used to enhance stability, yet their effects on chemical degradation remain insufficiently understood.
Methods
This study investigates how fructose, sucrose, melezitose, and the non-ionic surfactants polysorbate 80 and DDM (n-Dodecyl-β-D-maltoside) affect the structure and chemical stability of the affibody GA-Z, a protein prone to deamidation and isomerization. Chemical degradation and conformational changes were characterized using peptide fingerprinting, Liquid Chromatography-Mass Spectrometry, Titration fluorescence spectroscopy, two-dimensional Nuclear Magnetic Resonance spectroscopy, and Differential Scanning Calorimetry.
Results
All three sugars lowered chemical degradation by stabilizing the folded state of the z-domain and inducing minor structural changes in the albumin-binding domain, thereby lowering the propensity for deamidation and isomerization. Polysorbate 80 showed minimal impact on both degradation and protein structure. In contrast, DDM increased deamidation and isomerization due to surfactant–protein interactions, resulting in structural changes.
Conclusion
These results demonstrate how excipient-induced structural changes affect chemical degradation of proteins in liquid formulations. This study contributes to the understanding and design of more effective formulations for therapeutic proteins, enhancing their stability and safety. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Process and Life Science Engineering, Lund University, 221 00, Lund, Sweden.
- SARomics Biostructures AB, 223 63, Lund, Sweden.
- Research Institutes of Sweden, 114 28, Stockholm, Sweden.
- Global Research Technology, Novo Nordisk A/S, 2760, Måløv, Denmark.
- Department of Process and Life Science Engineering, Lund University, 221 00, Lund, Sweden. lars.nilsson@ple.lth.se.
- MAX IV Laboratory, Lund, Sweden. lars.nilsson@ple.lth.se.
Förderung
- VINNOVA
- Lund University
Zitieren
APA
Ramm, I., Diehl, C., Västberg, A., Hjalte, J., Schagerlöf, H., Wahlgren, M., & Nilsson, L. (2026). The Effect of Pharmaceutical Excipients on Protein Chemical Degradation Through Deamidation and Isomerization. Pharmaceutical Research, 43(4), 1227-1240. https://doi.org/10.1007/s11095-026-04040-4
Vancouver
Ramm I, Diehl C, Västberg A, Hjalte J, Schagerlöf H, Wahlgren M, et al. The Effect of Pharmaceutical Excipients on Protein Chemical Degradation Through Deamidation and Isomerization. Pharmaceutical Research. 2026;43(4):1227-1240. doi:10.1007/s11095-026-04040-4
BibTeX
@article{Ramm2026,
author = {Ramm, Ingrid and Diehl, Carl and Västberg, Amanda and Hjalte, Johanna and Schagerlöf, Herje and Wahlgren, Marie and Nilsson, Lars},
title = {The Effect of Pharmaceutical Excipients on Protein Chemical Degradation Through Deamidation and Isomerization},
journal = {Pharmaceutical Research},
year = {2026},
volume = {43},
number = {4},
pages = {1227--1240},
doi = {10.1007/s11095-026-04040-4}
}
EUVIMED